Novavax seeks expanded authorization for COVID vaccine in Europe for adolescents aged 12 to 17Market Watch • 03/31/22
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)PRNewsWire • 03/31/22
Thermo Fisher Scientific's PPD Clinical Research Business Earns TOPRA Award for Regulatory Affairs Excellence in Supporting Novavax's COVID-19 Vaccine ApprovalBusiness Wire • 03/30/22
3 Ultra-Popular Stocks That Could Soar 120%, 51%, and 109%, Wall Street SaysThe Motley Fool • 03/26/22
Novavax Announces Participation in Two Booster Studies Using its COVID-19 VaccinePRNewsWire • 03/25/22
Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 toPRNewsWire • 03/22/22